Evaluation Of Quality Of Life After Hepatectomy And Intervention(TAE) Treatment For Hepatic Hemangioma

Background:At the moment,There are no standardized indications for the treatment of Hepatic Hemangioma.The traditional treatment of hepatic Hemangioma is mainly surgical resection,this method of treatment is relatively large trauma and more complications.There are reports in the literature,The complication rate of surgical resection of Hepatic Hemangioma was 27%,the case fatality rate is 3%.For Benign tumors,surgical removal is a risky procedure,can be very stressful for both the patient and the doctor.In recent years,with the development of medical technology and technology,Transcatheter hepatic artery embolization(TAE)with less trauma、low risk and the advantage of significant efficacy in the treatment of Hepatic Hemangioma has been widely accepted by clinical and patients,has become one of the main methods of treatment.Objective:To investigate the differences in quality of life of patients with hepatic hemangioma after hepatectomy and percutaneous transcatheter arterial chemoembolization(TAE).Methods: A total of 179 patients with hepatic hemangioma treated in our hospital from December 2015 to December 2017 were retrospective analysis.Among them,131 patients were treated with hepatectomy(group A)and 48 patients were treated with TAE(group B).Observe the differences in liver function,renal function,coagulation function,tumor markers,operation time,intraoperative blood loss,postoperative complications,postoperative hospitalization days,hospitalization costs.And the telephone follow-up questionnaire survey,through the gastrointestinal quality of life index(GLQI Index)scale for investigation and analysis.determination of hepaticresection for Hepatic Hemangioma(group A)and Transcatheter hepatic artery embolization(group B),before and 1 month,3 months,6 months and 12 months after operaton of GLQI Index.The changes in quality of life of the two groups of patients were compared.Results:The alanine aminotransferase(ALT),aspartate aminotransferase(AST),creatinine,carcinoembryonic antigen(CEA),and alpha-fetoprotein(AFP)in group A were lower than those in group B(P <0.05).The time was higher than that of group B(P <0.05).The operation time,intraoperative blood loss,postoperative hospital stay,and hospitalization cost of group A were greater than those of group B(P <0.05),but the incidence of postoperative complications was lower than that of group B(P<0.05).There was no statistical difference in total GLQI between the two groups(P>0.05),but the overall changing trend of the total GLQI after operation was significantly different between the two groups(P <0.05).The GLQI score in group B increased from1-6 months after operation to the level before surgery(P <0.05).The GLQI score in group A continued to increase after surgery(P <0.05).The GLQI score at 3 months was lower than that of group B(P <0.05),and was the same as that of group B at 6 months after operation(P> 0.05),and was higher than that of group B at 12 months(P <0.05).Covclusion: Hepatectomy has exact curative effect on hepatic hemangiomas,has a low incidence of adverse reactions,and better than TAE for long-term improvement of quality of life in liver hemangioma patients.